EA201270475A1 - Комбинация - Google Patents
КомбинацияInfo
- Publication number
- EA201270475A1 EA201270475A1 EA201270475A EA201270475A EA201270475A1 EA 201270475 A1 EA201270475 A1 EA 201270475A1 EA 201270475 A EA201270475 A EA 201270475A EA 201270475 A EA201270475 A EA 201270475A EA 201270475 A1 EA201270475 A1 EA 201270475A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- treatment
- relates
- combinations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24626509P | 2009-09-28 | 2009-09-28 | |
| US38573810P | 2010-09-23 | 2010-09-23 | |
| PCT/US2010/050495 WO2011038380A2 (en) | 2009-09-28 | 2010-09-28 | Combination |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA201270475A1 true EA201270475A1 (ru) | 2012-11-30 |
Family
ID=43796526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201270475A EA201270475A1 (ru) | 2009-09-28 | 2010-09-28 | Комбинация |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20120245180A1 (https=) |
| EP (1) | EP2482819A4 (https=) |
| JP (1) | JP2013505962A (https=) |
| KR (1) | KR20120099217A (https=) |
| CN (1) | CN102665719A (https=) |
| AU (1) | AU2010298020B8 (https=) |
| BR (1) | BR112012006968A2 (https=) |
| CA (1) | CA2775874A1 (https=) |
| EA (1) | EA201270475A1 (https=) |
| IL (1) | IL218846A0 (https=) |
| MX (1) | MX2012003779A (https=) |
| WO (1) | WO2011038380A2 (https=) |
| ZA (1) | ZA201202258B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI505828B (zh) | 2010-12-20 | 2015-11-01 | 葛蘭素史克智慧財產（第二）有限公司 | 新穎醫藥組成物 |
| EP2943199A1 (en) * | 2013-01-09 | 2015-11-18 | Glaxosmithkline Intellectual Property (No. 2) Limited | Combination |
| WO2014169843A1 (en) * | 2013-04-18 | 2014-10-23 | Shanghai Fochon Pharmaceutical Co Ltd | Certain protein kinase inhibitors |
| WO2018126192A1 (en) * | 2016-12-30 | 2018-07-05 | Children's Medical Center Corporation | Map2k1 (mek1) as a therapeutic target for arteriovenous malformations and associated disorders |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7378423B2 (en) | 2004-06-11 | 2008-05-27 | Japan Tobacco Inc. | Pyrimidine compound and medical use thereof |
| AU2005252110B2 (en) * | 2004-06-11 | 2008-09-04 | Shionogi & Co., Ltd. | 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-D] pyrimidine derivatives and related compounds for the treatment of cancer |
| PE20060608A1 (es) * | 2004-10-13 | 2006-08-22 | Wyeth Corp | Analogos de 17-hidroxiwortmanina como inhibidores de pi3k |
| TW200815429A (en) | 2006-04-11 | 2008-04-01 | Smithkline Beecham Corp | Thiazolidinedione derivatives as PI3 kinase inhibitors |
| CN101528231A (zh) * | 2006-08-16 | 2009-09-09 | 埃克塞利希斯股份有限公司 | 在癌症的治疗中使用pi3k和mek调控剂 |
| PE20090717A1 (es) | 2007-05-18 | 2009-07-18 | Smithkline Beecham Corp | Derivados de quinolina como inhibidores de la pi3 quinasa |
-
2010
- 2010-09-28 MX MX2012003779A patent/MX2012003779A/es active IP Right Grant
- 2010-09-28 US US13/498,381 patent/US20120245180A1/en not_active Abandoned
- 2010-09-28 EP EP10819634A patent/EP2482819A4/en not_active Withdrawn
- 2010-09-28 EA EA201270475A patent/EA201270475A1/ru unknown
- 2010-09-28 AU AU2010298020A patent/AU2010298020B8/en not_active Ceased
- 2010-09-28 KR KR1020127010300A patent/KR20120099217A/ko not_active Withdrawn
- 2010-09-28 CN CN2010800538226A patent/CN102665719A/zh active Pending
- 2010-09-28 WO PCT/US2010/050495 patent/WO2011038380A2/en not_active Ceased
- 2010-09-28 JP JP2012531109A patent/JP2013505962A/ja active Pending
- 2010-09-28 BR BR112012006968A patent/BR112012006968A2/pt not_active IP Right Cessation
- 2010-09-28 CA CA2775874A patent/CA2775874A1/en not_active Abandoned
-
2012
- 2012-03-26 IL IL218846A patent/IL218846A0/en unknown
- 2012-03-28 ZA ZA2012/02258A patent/ZA201202258B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2010298020B2 (en) | 2013-09-12 |
| BR112012006968A2 (pt) | 2019-09-24 |
| US20120245180A1 (en) | 2012-09-27 |
| AU2010298020B8 (en) | 2013-10-10 |
| EP2482819A2 (en) | 2012-08-08 |
| MX2012003779A (es) | 2012-06-01 |
| WO2011038380A3 (en) | 2011-09-15 |
| AU2010298020A1 (en) | 2012-04-19 |
| JP2013505962A (ja) | 2013-02-21 |
| IL218846A0 (en) | 2012-06-28 |
| AU2010298020A8 (en) | 2013-10-10 |
| EP2482819A4 (en) | 2013-02-20 |
| WO2011038380A2 (en) | 2011-03-31 |
| CN102665719A (zh) | 2012-09-12 |
| KR20120099217A (ko) | 2012-09-07 |
| ZA201202258B (en) | 2012-10-31 |
| CA2775874A1 (en) | 2011-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201270537A1 (ru) | Комбинация | |
| NZ610746A (en) | Methods of treatment using selective bcl-2 inhibitors | |
| RU2016141569A (ru) | Комбинации | |
| WO2010011772A3 (en) | Tri-cyclic pyrazolopyridine kinase inhibitors | |
| UA114906C2 (uk) | Гетероциклільні сполуки як інгібітори мек | |
| AU2012243329A8 (en) | 5-substituted iminothiazines and their mono-and dioxides as BACE inhibitors,compositions,and their use | |
| NZ700761A (en) | Salt form of a human histone methyltransferase ezh2 inhibitor | |
| EA201391486A1 (ru) | Способы и композиции для лечения болезни паркинсона | |
| SG10201407409WA (en) | Inhibitors of jun n-terminal kinase | |
| CL2014000492A1 (es) | Compuestos derivados de n-[3-(1,2,4-oxadiazol-(5-il/amino/carbamoil)fenil]imidazo[1,2-a]pirdina-3-carboxamida, inhibidores de la quinasa c-kit; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer, artritis, aterosclerosis, entre otras | |
| MX2014002113A (es) | Iminotiazinas sustituidas en 2-espiro y sus mono y bioxidos como inhibidores de enzima de disociacion de proteina precursora amiloide del sitio beta, composiciones, y su uso. | |
| MX2009009592A (es) | Aminopiridinas utiles como inhibidores de proteinas cinasas. | |
| RU2014120792A (ru) | Способ лечения стромальных опухолей желудочно-кишечного тракта | |
| MX336051B (es) | Diarilacetileno hidracido que contiene inhibidores de tirosina quinasa. | |
| TW200738729A (en) | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | |
| WO2007120760A3 (en) | Thiophene-carboxamides useful as inhibitors of protein kinases | |
| MX2015017629A (es) | Combinaciones farmaceuticas. | |
| UA107353C2 (en) | Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof | |
| CL2013001591A1 (es) | Compuestos derivados de triazolopiridina; inhibidores de pde10a; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento o profilaxis de trastornos psicoticos, esquizofrenia, ansiedad, entre otras enfermedades. | |
| MY202114A (en) | Treatment of brain cancer | |
| GEP20207098B (en) | Compounds having muscarinic receptor antagonist and beta2 adrenergic receptor agonist activity | |
| EA201270475A1 (ru) | Комбинация | |
| WO2014130752A3 (en) | Bicyclic compounds | |
| WO2009045992A3 (en) | C-met protein kinase inhibitors | |
| WO2006057922A3 (en) | Niacin receptor agonists, compositions containing such compounds and methods of treatment |